A new binuclear Ni(II) complex, an effective A3-coupling catalyst in solvent-free condition.

A newly binuclear nickel(II) complex, [Ni2(en)4(ox)](ClO4)2 (1) (where en = ethylenediamine, and ox = oxalate), has been isolated from a reaction of NiCl2·6H2O, ethylenediamine, ammonium oxalate and sodium perchlorate in water and its crystal structure has been determined by X-ray crystallography and infra-red techniques. Compound 1 was successfully employed to promote the one-pot reaction of aldehydes, amines and acetylenes for the construction of corresponding propargylamines under solvent-free media with fine yields. Further studies reveal this catalytic system can be refreshed and used again in five runs.

Investigating of the anticancer activity of salen/salophen metal complexes based on graphene quantum dots: Induction of apoptosis as part of biological activity.

This research work is the first report on the synthesis and stabilization of [Fe-Salophen] and [Fe-Salen] complexes by two methods of surface modification and anchoring of synthesized Schiff base ligand on the surface of graphene quantum dots (GQDs). The GQDs contain oxygenated functional groups that can act as non-radiative electron-hole recombination centers. Therefore removing these oxygen functional groups may improve quantum yield by reducing or deactivating the surface. In this work, GQDs with the amine functional group were synthesized with a quantum yield of 37.48%. The physicochemical properties of GQDs were investigated by Ultraviolet-visible (UV-Vis) and fluorescence spectroscopies, Fourier-transform infrared spectroscopy (FTIR), scanning electron microscopy (FESEM), X-ray photoelectron spectroscopy (XPS), Powder X-ray diffraction (PXRD), Transmission electron microscope (TEM). The synthesis of GQDs-[Fe-Salen] and GQDs-[Fe-Salophen] was evaluated by FT-IR, Inductively coupled plasma atomic emission spectroscopy (ICP-AES) and Energy dispersive X-Ray analysis (EDX) analyses. Then, using MTT- assay, annexin V-FITC/PI, DAPI staining and cellular uptake assays, the biochemical activity of these complexes on the MCF7 cell line was investigated. The results shows that GQDs-[Fe-Salen] and GQDs-[Fe-Salophen] affect the survival of MCF7 cancer cells and, by nuclear fragmentation cause 35.77% and 19.41% of early apoptosis in cells, respectively. Also was found cellular uptake of GQDs-[Fe-Salen] is higher than that of GQDs-[Fe-Salophen].

Enhanced anticancer potency with reduced nephrotoxicity of newly synthesized platin-based complexes compared with cisplatin.

As a platinum-containing anticancer drug, cisplatin is the keystone for treating many malignancies. Nephrotoxicity is the main dose-limiting toxicity, and several hydration therapies and supplementary strategies are utilized to reduce cisplatin-induced kidney damage, so the discovery and development of effective and safe antitumor drugs are still on the path of human health. Herein, a new four-coordinated Pt complex [Pt(TSC)Cl] using N(4)-phenyl-2-formylpyridine thiosemicarbazone (HTSC) was synthesized and characterized by single-crystal X-ray diffraction, 1HNMR, FT-IR, LC/MS and CHN elemental analysis. The Pt(TSC)Cl complex revealed antiproliferative activity against A549, MCF-7 and Caco-2 cell lines with a low micromolar IC50 (200-1.75 µM). Specifically, the Pt(TSC)Cl complex displayed more selectivity in Caco-2 cells (IC50 = 2.3 µM) than cisplatin (IC50 = 107 µM) after 48 h of treatment. Moreover, compared with cisplatin, a known nephrotoxic drug, the Pt(TSC)Cl complex exhibited lower nephrotoxicity against Hek293 normal cells. We also found that the Pt(TSC)Cl complex can effectively prevent cancer cell propagation in sub-G1 and S phases and induce apoptosis (more than 90%). Real time PCR and western analysis demonstrated that the expression pattern of apoptotic genes and proteins is according to the intrinsic apoptosis pathway through the Bax/Bcl-2-Casp9-Casp3/Casp7 axis. Collectively, our findings indicated that the Pt(TSC)Cl complex triggers apoptosis in Caco-2 cell lines, while low nephrotoxicity was shown and may be considered a useful anticancer drug candidate for colorectal cancers for further optimization and growth.

Antimicrobial, cytotoxicity, molecular modeling and DNA cleavage/binding studies of zinc-naproxen complex: switching DNA binding mode of naproxen by coordination to zinc ion.

The intercalation DNA binding mode of the naproxen, a non-steroidal anti-inflammatory drug, has been reported previously. In this study, calf thymus deoxyribonucleic acid (CT-DNA) binding of zinc-naproxen complex, [Zn(naproxen)2(MeOH)2], at physiological pH has been investigated by multi-spectroscopic techniques and molecular docking. Zinc-naproxen complex displays significant binding property to the CT-DNA (Kb = 0.2 × 105 L.mol-1). All of the experimental results; relative increasing in viscosity of CT-DNA and fluorimetric studies using ethidium bromide (EB) and Hoechst 33258 probes, are indicative of groove binding mode of zinc-naproxen complex to CT-DNA. These results show that the coordination of naproxen to zinc metal switches the mode of binding from intercalation to groove. The molecular modeling also shows that the complex binds to the AT-rich region of minor groove of DNA. Structural and topography changes of DNA in interaction with the complex by atomic force microscopy (AFM) indicated that CT-DNA becomes swollen after interaction. The pUC18 plasmid DNA cleavage ability of zinc-naproxen complex by gel electrophoresis experiments revealed that zinc-naproxen complex cleaved supercoiled pUC18 plasmid DNA to nicked DNA. The cytotoxicity of the zinc complex performed by MTT method on HT29 and MCF7 cancer cell lines and on HEK 293 normal cell lines indicates that zinc complex has no cytotoxic effect on both HT29 and MCF7 cell lines but has better cytotoxicity effect on HEK 293 cell lines compared to cisplatin standard drug. The antimicrobial activity of the complex against Staphylococcus aureus and Escherichia coli bacteria revealed the high antimicrobial activity of the complex.Communicated by Ramaswamy H. Sarma.

Investigation of biological activity of nickel (II) complex with naproxen and 1,10-phenanthroline ligands.

After the accidental discovery of cis-platinum, extensive attempts have centralized on the rational design of metallic compounds for cancer treatment. Here a solvent-dependent complex of nickel (II) with 1,10-phenanthroline and naproxen, [Ni(1,10-phenanthroline)(naproxen)2(solvent)], solvent = 83% H2O and 17% EtOH in the crystal structure, has been synthesized and specified by the X-ray structure analysis. It's in vitro DNA binding was inspected by the multispectroscopic methods and gel electrophoresis. The data of DNA-viscosity and competition fluorimetric test by methylene blue (MB) and Hoechst 33258 confirm groove binding mode of the complex to CT-DNA. Comparison of the results of this binding study with previous work revealed that the mode of binding of small compounds to DNA is highly influenced by the structure of the compounds. The DNA cleavage potency of the complex was appraised by the agarose gel electrophoretic and it was found that the complex does not have any momentous cleavage potency on the pUC18 plasmid DNA. The cytotoxicity of the complex on HT 29, HepG2 and HEK-293 cell lines by MTT method indicates that %inhibition of the complex on HT 29 is better than HepG2, compared with cisplatin drug. On HEK-293 cells, %inhibition growth of normal cells of the complex is less than cisplatin. Flow cytometry analysis of the complex on the HT 29 cells indicated the apoptosis cell death. RT-PCR studies revealed down-regulation of BCL2 expression, while the expression of BAX, caspase 3 and BAX/BCL2 genes was up-regulated in HT 29 cells by the complex. HighlightsA solvent-dependent nickel (II) with naproxen and 1,10-phenanthroline with aqueous solubility was synthesized and characterized.All experimental results indicate a groove mode of binding of the complex to CT-DNA.Potential biological characteristics confirmed that the complex is a promising candidate as anticancer agent.Communicated by Ramaswamy H. Sarma.

In vitro nephrotoxicity and anticancer potency of newly synthesized cadmium complexes.

Complexes based on heavy metals have great potential for the treatment of a wide variety of cancers but their use is often limited due to toxic side effects. Here we describe the synthesis of two new cadmium complexes using N(4)-phenyl-2-formylpyridine thiosemicarbazone (L1) and 5-aminotetrazole (L2) as organic ligands and the evaluation of their anti-cancer and nephrotoxic potential in vitro. The complexes were characterized by Single-crystal X-ray data diffraction, 1HNMR, FT-IR, LC/MS spectrometry and CHN elemental analysis. Next, cytotoxicity of these cadmium complexes was evaluated in several cancer cell lines, including MCF-7 (breast), Caco-2 (colorectal) and cisplatin-resistant A549 (lung) cancer cell lines, as well as in conditionally-immortalized renal proximal tubule epithelial cell lines for evaluating nephrotoxicity compared to cisplatin. We found that both compounds were toxic to the cancer cell lines in a cell-cycle dependent manner and induced caspase-mediated apoptosis and caspase-independent cell death. Nephrotoxicity of these compounds was compared to cisplatin, a known nephrotoxic drug, in vitro. Our results demonstrate that compound {2}, but not compound {1}, exerts increased cytotoxicity in MCF-7 and A549 cell lines, combined with reduced nephrotoxic potential compared to cisplatin. Together these data make compound {2} a likely candidate for further development in cancer treatment.

Crystal structure and Hirshfeld surface analysis of di-iodido-{N'-[(E)-(phen-yl)(pyridin-2-yl-κN)methylidene]pyridine-2-carbohydrazide-κ2 N',O}cadmium(II).

In each of the two independent mol-ecules in the asymmetric unit of the title compound, [CdI2(C18H14N4O)], the N,O,N'-tridentate N'-[(E)-(phen-yl)(pyridin-2-yl-κN)methyl-idene]pyridine-2-carbohydrazide ligand and two iodide anions form an I2N2O penta-coordination sphere, with a distorted square-pyramidal geometry, with an I atom in the apical position. Both mol-ecules feature an intra-molecular N-H⋯N hydrogen bond. In the crystal, weak aromatic π-π stacking inter-actions [centroid-centroid separation = 3.830 (2) Å] link the mol-ecules into dimers.

Structural versatility of the quasi-aromatic Möbius type zinc(ii)-pseudohalide complexes - experimental and theoretical investigations.

In this contribution we report for the first time fabrication, isolation, structural and theoretical characterization of the quasi-aromatic Möbius complexes [Zn(NCS)2LI] (1), [Zn2(µ1,1-N3)2(LI)2][ZnCl3(MeOH)]2·6MeOH (2) and [Zn(NCS)LII]2[Zn(NCS)4]·MeOH (3), constructed from 1,2-diphenyl-1,2-bis((phenyl(pyridin-2-yl)methylene)hydrazono)ethane (LI) or benzilbis(acetylpyridin-2-yl)methylidenehydrazone (LII), respectively, and ZnCl2 mixed with NH4NCS or NaN3. Structures 1-3 are dictated by both the bulkiness of the organic ligand and the nature of the inorganic counter ion. As evidenced from single crystal X-ray diffraction data species 1 has a neutral discrete heteroleptic mononuclear structure, whereas, complexes 2 and 3 exhibit a salt-like structure. Each structure contains a ZnII atom chelated by one tetradentate twisted ligand LI creating the unusual Möbius type topology. Theoretical investigations based on the EDDB method allowed us to determine that it constitutes the quasi-aromatic Möbius motif where a metal only induces the π-delocalization solely within the ligand part: 2.44|e| in 3, 3.14|e| in 2 and 3.44|e| in 1. It is found, that the degree of quasi-aromatic π-delocalization in the case of zinc species is significantly weaker (by ∼50%) than the corresponding estimations for cadmium systems - it is associated with the Zn-N bonds being more polar than the related Cd-N connections. The ETS-NOCV showed, that the monomers in 1 are bonded primarily through London dispersion forces, whereas long-range electrostatic stabilization is crucial in 2 and 3. A number of non-covalent interactions are additionally identified in the lattices of 1-3.

Correction: Structural versatility of the quasi-aromatic Möbius type zinc(ii)-pseudohalide complexes - experimental and theoretical investigations.

[This corrects the article DOI: 10.1039/C9RA05276C.].

Crystal structures of di-bromido-{N-[(pyridin-2-yl-κN)methyl-idene]picolinohydrazide-κ2N',O}cadmium methanol monosolvate and di-iodido{N-[(pyridin-2-yl-κN)methyl-idene]picolinohydrazide-κ2N',O}cadmium.

The title compounds, [CdBr2(C12H10N4O)]·CH3OH, (I), and [CdI2(C12H10N4O)], (II), are cadmium bromide and cadmium iodide complexes of the ligand (E)-N'-(pyridin-2-yl-methyl-ene)picolinohydrazide. Complex (I) crystallizes as the methanol monosolvate. In both compounds, the Cd2+ cation is ligated by one O atom and two N atoms of the tridentate ligand, and by two bromide anions forming a Br2N2O penta-coordination sphere for (I), and by two iodide anions forming an I2N2O penta-coordination sphere for (II), both with a distorted square-pyramidal geometry. In the crystal of complex (I), mol-ecules are linked by pairs of N-H⋯O and O-H⋯Br hydrogen bonds, involving the solvent mol-ecule, forming dimeric units, which are linked by C-H⋯Br hydrogen bonds forming layers parallel to (101). In the crystal of complex (II), mol-ecules are linked by N-H⋯I hydrogen bonds, forming chains propagating along [010]. In complex (II), measured at room temperature, the two iodide anions are each disordered over two sites; the refined occupancy ratio is 0.75 (2):0.25 (2).

Di-µ-chlorido-bis-(chlorido-{N'-[phen-yl(pyridin-2-yl-κN)methyl-idene]pyridine-2-carbohydrazide-κ(2) N',O}cadmium).

The title compound, [Cd2Cl4(C18H14N4O)2], was obtained from the reaction of Cd(NO3)2·4H2O with 2-phenyl-pyridine-keton picolinoyl hydrazone and sodium chloride. Each Cd(2+) cation is coordinated by two N atoms and one O atom of the tridentate ligand and three chloride anions, forming a distorted CdNOCl3 octahedron. Each pair of adjacent metal cations is linked by two bridging chloride ligands, resulting in a dinuclear complex unit. The mol-ecular conformation is stabilized by intra-molecular N-H⋯N and C-H⋯O hydrogen bonds. In the crystal, mol-ecules are linked by nonclassical C-H⋯O and C-H⋯Cl hydrogen bonds into a three-dimensional network. In addition, π-π stacking inter-actions [centroid-centroid distances = 3.777 (2) and 3.631 (2) Å] contribute to the stabilization of the crystal packing.

Optical spectroscopy studies of the complexation of bis(azophenol)calix[4]arene possessing chromogenic donors with Ni2+, Co2+, Cu2+, Pb2+ and Hg2+.

Due to their potential applicability as selective receptors in electrochemical or optical sensors, a bis(azophenol)calix[4]arene derivative H(2)L has been investigated. The complexation properties of this molecule towards Ni(2+) and Co(2+) metal ions has been studied. It is revealed that this ligand exhibits tetradentate with N(2)O(2) core when bound to Ni (II) or Co (II) metal ion. The optical response of azo groups of H(2)L towards Ni(2+), Co(2+), Cu(2+), Pb(2+) and Hg(2+) metal ions has been investigated in DMSO by UV-vis spectroscopy. The absorption spectra of calix[4]arene with cations show marked changes, especially for Co(2+) ion. Furthermore, Job's plot indicate 1:1 binding-stiochiometry for calix[4]arene with Co(2+) ion and Benson-Hilderbrand plot is used for the determination of its association constant. The investigation of UV-vis spectra of chromogenic calix[4]arene in different solvents shows that cis-trans isomerization of azo groups probably depends on kind of solvent. Also the different between the polarity and viscosity of organic solvents used is likely responsible for the changes of the band shape of the spectra.

catena-Poly[[(benzil bis{[(pyridin-2-yl)methylidene]hydrazone}-κ4N,N',N'',N''')mercury(II)]-µ-chlorido-[dichloridomercury(II)]-µ-chlorido].

In the title coordination polymer, [Hg4Cl4(C26H20N6)](n), one Hg(II) ion is coordinated by four N atoms from the benzylbis((pyridin-2-yl)methyl-idenehydrazone) ligand and two Cl⁻ ions in a very distorted cis-HgCl2N4 octa-hedral geometry. The other Hg(II) ion is coordinated in a distorted tetra-hedral geometry by four Cl⁻ ions. Bridging chloride ions link the Hg(II) ions into a chain propagating in [010]: the Hg-Cl bridging bonds are significantly longer than the terminal bonds. The dihedral angle between the central benzene rings of the ligand is 83.3 (2)°. The packing is consolidated by weak C-H⋯Cl hydrogen bonds and C-H⋯π inter-actions.

Dibromido{N'-[1-(pyridin-2-yl)ethyl-idene]picolinohydrazide-κ(2)N',O}cadmium.

The title compound, [CdBr(2)(C(13)H(12)N(4)O)], was obtained from the reaction of Cd(NO(3))(2)·4H(2)O with meth-yl(pyridin-2-yl)methanone picolinoylhydrazone and sodium bromide. The Cd(2+) cation is ligated by one O atom and two N atoms of the tridentate ligand and two bromide anions, forming a Br(2)CdN(2)O polyhedron with a distorted trigonal-bipyramidal coordination geometry. In the crystal, non-classical C-H⋯Br hydrogen bonds are observed. In addition, π-π stacking inter-actions [centroid-centroid distance = 3.7455 (19) Å] contribute to the stabilization of the crystal structure.

Syntheses, characterization and study of the use of cobalt (II) Schiff-base complexes as catalysts for the oxidation of styrene by molecular oxygen.

Schiff-Base complexes of bis-5-phenylazosalicylaldehyde ethylenediimine and bis-5-phenylazosalicylaldehyde-O-phenylenediimine ligands with Co(II) (I and II) have been synthesized and characterized by their IR spectra and elemental analyses. These complexes catalyze the oxidation of styrene in the presence of dioxygen and excess pyridine. The effect of the reaction conditions on the oxidation of styrene was studied by varying solvent, nature and amount of the catalyst and substrate. The catalytic behavior of the studied complexes was shown to be dependent on the conditions applied. In all reactions, acetophenone and 1- phenylethanol were the only observed products.